ARS Pharmaceuticals(SPRY) - 2024 Q4 - Earnings Call Transcript
ARS Pharmaceuticals (SPRY) Q4 2024 Earnings Call March 20, 2025 08:30 AM ET Company Participants Justin Chakma - Chief Business Officer & SecretaryRichard Lowenthal - Founder, President, CEO & DirectorEric Karas - Chief Commercial OfficerKathleen Scott - Chief Financial OfficerRyan Deschner - Vice President - Equity ResearchAlexa Deemer - Biotechnology Equity Research AssociateLouise Chen - Managing DirectorJulian Harrison - Managing Director Conference Call Participants Roanna Ruiz - Senior Managing Direct ...